Influence of azelaic acid on acne pathogenesis

Cover Page

Cite item


I In current literature review the physicochemical properties, peculiarities of mode of action and pharmacokinetics of azelaic and influence of azelaic on pathogenetic aspects of acne are characterized.

About the authors

A. N. Khlebnikova

I.M. Sechenov First Moscow State Medical University

Author for correspondence.
Russian Federation


  1. Federal clinical guidelines for treatment of patients with acne. A.V. Samtsov, E.R. Araviyskaya (eds.). Moscow 2013 - 20 p. [Федеральные клинические рекомендации по ведению больных акне. Под ред. А.В. Самцова, Е.Р. Аравийской. М, 2013. 20.]
  2. Hollnick H.P., Zouboulis C.C. Not all acne is acne vulgaris. Dtsch Arztebl Int 2014; 111: 301-12.
  3. Pawin H., Chivot M., Beylot C. et al. Living with acne. A study of adolescents’personal experiences. Dermatology 2007; 215 (4): 308-314.
  4. Franzke N., Zimmer L., Schäfer I., Radermacher C., Kresken J., Augustin M. Quality of medical care of patients with acne vulgaris in Germany - nationwide survey of pharmacy clients. J Dtsch Dermatol Ges 2009; 7: 1060-3.
  5. Plewig G., Kligman A.M., editors. Acne and Rosacea, 3rd ed. Berlin, Germany: Springer-Verlag 2000; 756.
  6. Krishna S., Kim C., Kim J. Innate immunity in the pathogenesis of acne vulgaris. In: Shalita A.R., Del Rosso J.Q., Webster G.F., editors. Acne Vulgaris. London: Informa Healthcare; 2011; 12-27.
  7. Collier C.N., Harper J.C., Cafardi J.A. et al. The prevalence of acne in adults 20 years and older. J Am Acad Dermatol 2008; 58 (1): 56-59.
  8. Fitton A., Goa K.L. Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders. Drugs 1991; 41 (5): 780-98. Литература
  9. Caprilli F., Mercantini R., Nazzaro-Porro M. et al. Studies of the genus Pityrosporum in submerged culture. Mycopathologia et Mycologia Applicata 1973; 51: 171-189.
  10. Nazzaro-Porro M., Passi S. Identification of tyrosinase inhibitors in cultures of Pityrosporum. J Invest Dermatol 1978; 71: 205-208.
  11. Nguyen Q.H., Bui T.P. Azelaic acid: pharmacokinetic and pharmacodynamic properties and its therapeutic role in hyperpigmentary disorders and acne. Int J Dermatol 1995; 34 (2): 75-84.
  12. Nazzaro-Porro M., Passi S., Picardo M. et al. Beneficial effect of 15% azelaic acid cream on acne vulgaris, Br J Dermatol 1983; 109: 45-48.
  13. Draelos Z.D. The rationale for advancing the formulation of azelaic acid vehicles. Cutis 2006; 77: 7-11.
  14. Maru U., Michaud P., Garrigue J., Oustrin J., Rouffiac R. In vitro diffusion and skin penetration of azelaic preparations: study of correlations (in French). J Pharm Belg 1982; 37: 207-213.
  15. Tauber U., Weiss C., Matthes H. Percutaneous absorption of azelaic acid in humans. Exp Dermatol 1992; 1: 176-179.
  16. Breathnach A., Nazzaro-Porro M., Passi S., Zina G. Azelaic acid therapy in disorders of pigmentation. Clinics Dermatol 1989; 7:106-119.
  17. Gollnick H.P., Krautheim A. Topical treatment in acne: current status and future aspects. Dermatology 2003; 206: 29-36.
  18. Bojar R.A., Cutcliffe A.G., Graupe K., Cunliffe W.J., Holland K.T. Follicular concentrations of azelaic acid after a single topical application. Br J Dermatol 1993; 129: 399-402.
  19. Passi S., Nazzaro-Porro M., Picardo M. et al. Metabolism of straight saturated medium chain length C9 to C12 dicarboxylic acids. J Lipid Res 1983; 24: 1140-1147.
  20. Del Rosso J.Q., Lehman P.A., Raney S.G. Impact of order of application of moisturizers on percutaneous absorption kinetics: evaluation of sequential application of moisturizer lotions and azelaic acid gel 15% using a human skin model. Cutis 2009; 83: 119-124.
  21. Mastrofrancesco A., Ottaviani M., Aspite N., Cardinali G., Izzo E. et al. Azelaic acid modulates the inflammatory response in normal human keratinocytes through PPARy activation. Exp Dermatol 2010; 19: 813-820.
  22. Briganti S., Flori E., Mastrofrancesco A., Kovacs D., Camera E. et al. Azelaic acid reduced senescencelike phenotype in photo-irradiated human dermal fibroblasts: possible implication of PPARy. Exp Dermatol 2013; 22: 41-47.
  23. Akamatsu H., Komura J., Asada Y., Miyachi Y., Niwa Y. Inhibitory effect of azelaic acid on neutrophil functions: a possible cause for its efficacy in treating pathogenetically unrelated diseases. Arch Dermatol Res 1991; 283: 162-166.
  24. Passi S., Picardo M., De Luca C., Breathnach A.S., Nazzaro-Porro M: Scavenging activity of azelaic acid on hydroxyl radicals ‘in vitro’. Free Radic Res Commun 1991; 11: 329-338.
  25. Leeming J., Holland K., Bojar R. The in vitro antimicrobial effect of azelaic acid. Br J Dermatol 1986; 115: 551-556.
  26. King K., Leeming J., Holland K., Cunliffe W. The effect of azelaic acid on cutaneous microflora in vivo and in vitro. J Invest Dermatol 1985; 84: 438.
  27. Ozkan M., Durmaz G., Sabuncu I., Saracoglu N., Akgun Y., Urer S. Clinical efficacy of topical clindamycin phosphate and azelaic acid on acne vulgaris and emergence of resistant coagulase-negative Staphylococci. Turk J Med Sci 2000; 30: 483-487.
  28. Maple P.A., Hamilton-Miller J.M., Brumfitt W. Comparison of the in-vitro activities of the topical antimicrobials azelaic acid, nitrofurazone, silver sulphadiazine and mupirocin against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 1992; 29: 661-668.
  29. Bladon P.T., Burke B.M., Cunliffe W.J., Forster R.A., Holland K.T., King K. Topical azelaic acid and the treatment of acne: a clinical and laboratory comparison with oral tetracycline. Br J Dermatol 1986; 114: 493-499.
  30. Cunliffe W.J., Holland K.T. Clinical and laboratory studies on treatment with 20% azelaic acid cream for acne. Acta Derm Venereol Suppl (Stockh) 1989; 143: 31-34.
  31. Farag A., Ananieva L. Acne vulgaris: ultrastructure changes after treatment with 20% azelaic acid. J Dermatolog Treat 1995; 6: 151-154.
  32. Bojar R.A., Cutcliffe A.G., Graupe K., Cunliffe W.J., Holland K.T. Follicular concentrations of azelaic acid after a single topical application. Br J Dermatol 1993; 129: 399-402.
  33. King K., Leeming J.P., Holland K.T., Cunliffe W.J. The effect of azelaic acid on cutaneous microflora in vivo and in vitro. J Invest Dermatol 1985; 84: 438.
  34. Bojar R.A., Cunliffe W.J., Holland K.T. Disruption of the transmembrane pH gradient - a possible mechanism for the antibacterial action of azelaic acid in Propionibacterium acnes and Staphylococcus epidermidis. J Antimicrob Che-mother 1994; 34: 321-330.
  35. Bojar R.A., Holland K.T., Cunliffe W.J. The in-vitro antimicrobial effects of azelaic acid upon Propionibacterium acnes strain P37. J Antimicrob Chemother 1991; 28: 843-853.
  36. Bojar R.A., Cutcliffe A.G., Graupe K., Cunliffe W.J., Holland K.T. Azelaic acid: a review of its antimicrobial properties. Rec Contemp Pharacother 1993; 4: 403-414.
  37. Mayer-da-Silva A., Gollnick H., Detmar M., Gassmuller J. et al. Effects of azelaic acid on sebaceous gland, sebum excretion rate and keratinization pattern in human skin. An in vivo and in vitro study. Acta Derm Venereol Suppl (Stockh) 1989; 143: 20-30.
  38. Gollnick H., Mayer-da-Silva A., Orfanos C.E. Effects of azelaic acid on filaggrin, other cytokeratins and on the ultrastructure of human keratino-cytes in vivo. J Invest Dermatol 1987; 89: 452.
  39. Barbareschi M., Hendricks I., Angius A., Cattaneo M., Monti M. The anticomedonic activity of azelaic acid investigated by means of scanning electron microscopy on horny layer biopsy. J Dermatolog Treat 1991; 2: 55-57.
  40. Geier G., Hauschild T., Bauer R., Kreysel H. Der Einfluss von Azelainsaure auf das Wachstum von Melanomzellkulturen im Vergleich zu Fibroblastenkulturen, Hautarzt 1986; 37: 146-148.
  41. Galhaup I. Azelaic acid: mode of action at cellular and subcellular levels. Acta Derm Venereol [Suppl] (Stockh) 1989; 143: 75-82.
  42. Passi S., Picardo M., Mingrone G. et al. Azelaic acid: biochemistry and metabolism. Acta Derm Venereol [Suppl] (Stockh) 1989; 143: 8-13.
  43. Iraji F., Sadeghinia A., Shahmoradi Z., Siadat A.H., Jooya A. Efficacy of topical azelaic acid gel in the treatment of mild-moderate acne vulgaris. Indian J Dermatol Venereol Leprol 2007; 73: 94-96.
  44. Angius A.G., Barbareschi M., Cattaneo M., Monti M., Caputo R. Evaluation of the anticomedo effect of azelaic acid using the technique of horny layer biopsy and scanning electron microscopy (in Italian). G Ital Dermatol Venereol 1990; 125: XXXIII-XXXVI.
  45. Katsambas A., Graupe K., Stratigos J. Clinical studies of 20% azelaic acid cream in the treatment of acne vulgaris. Comparison with vehicle and topical tretinoin. Acta Derm Venereol Suppl (Stockh) 1989; 143: 35-39.
  46. Stamatiadis D., Bulteau-Portois M.C., Mowszowicz I. Inhibition of 5a-reductase activity in human skin by zinc and azelaic acid. Br J Dermatol 1988; 119: 627-632.
  47. Limburg J., Zettergren J., Swanson J. et al. Topical effect of 6-Methylene progesterone and azelaic acid on hamster ear sebaceous gland lipogenesis and morphology. J Invest Dermatol 1989; 92: 472.
  48. Rach P., Topert M. Pharmacological investigation of azelaic acid. J Invest Dermatol 1986; 86: 327.
  49. Mingrone G., Greco A., Nazzaro-Porro M., Passi S. Toxicity of azelaic acid. Drugs Exp Clin Res 1983; 9: 447-455.
  50. Topert M., Rach P., Siegmund F. Pharmacology and toxicology of azelaic acid. Acta Derm Venereol [Suppl] (Stockh) 1989; 143: 14-19.
  51. Bertuzzi A., Gandolfi A., Salinari S. et al. Pharmacokinetic analysis of azelaic acid disodium salt. A proposed substrate for total parenteral nutrition. Clin Pharmacokinet 1991; 20: 411-419.
  52. Willshaw H.E., Rubinstein K. Azelaic acid in the treatment of ocular and adnexal malignant melanoma. Br J Ophthalmol 1983; 67: 54-57.
  53. Gavicchini S., Gaputo R. Long-term treatment of acne with 20% azelaic cream. Acta Derm Venereol [Suppl] (Stockh) 1989; 143: 40-44.
  54. Verallo-Rowell V.M., Verallo V., Graupe K. et al. Double-blind comparison of azelaic acid and hydroquinone in the treatment of melasma. Acta Derm Venereol [Suppl] (Stockh) 1989; 143: 58-61.
  55. Graupe K., Cunliffe W.J., Gollnick H.P., Zaumseil R.P. Efficacy and safety of topical azelaic acid (20 percent cream): an overview of results from European clinical trials and experimental reports. Cutis 1996; 57: 20-35.
  56. Ortonne J.P., Lacour J.P. Assessment of the phototoxicity of azelaic acid using the modified method of Kaidbey and Kligman. Nouv Dermatol 1992; 11: 490-495.
  57. Ferguson J., Johnson B.E. Retinoid associated phototoxicity and photosensitivity. Pharmacol Ther 1989; 40: 123-135.
  58. Onoue S., Seto Y., Gandy G., Yamada S. Drug induced phototoxicity; an early in vitro identification of phototoxic potential of new drug entities in drug discovery and development. Curr Drug Saf 2009; 4: 123-136.

Copyright (c) 2015 Khlebnikova A.І.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies